Close Menu

University of Manchester

ProteoMonitor spoke to Tony Whetton, Head of the School for Cancer and Enabling Sciences at the University of Manchester, about his work applying proteomics to stem cell research.

A Myconostica official said this week that the company will debut a MycArray Mold ID array by the beginning of 2012 that will be designed to identify different species of microscopic fungi.

Under the terms of the agreement, Link will manufacture and sell diagnostic reagents based on the so-called exciplex technology, which is able to reduce the background fluorescent signal in nucleic acid assays in order to improve the detection sensitivity.

The company will make and sell a Manchester-developed diagnostic reagent technology through an agreement that includes a research collaboration.

The company is looking to differentiate itself from other players in the miRNA array market — such as Agilent Technologies, Life Technologies, Exiqon, and Febit — by stressing the "quality, performance, and affordability" of its OneArray platform.

The university will use the system in its stem cell and leukemia proteomics studies.

Pages

Researchers tie a variant in ADAMTS3 to breathing difficulties in dissimilar dog breeds, according to Discover's D-brief blog.

The Japan Times reports that researchers sequenced the genome of a woman who lived during the Jomon period.

Parents of children with rare genetic disease have to contend with shifts in the interpretation of genetic variants, the Wall Street Journal reports.

In Science this week: single-nucleus RNA sequencing of brain tissue from individuals with autism, and more.